26 Results

People

  1. Brentjens
    Brentjens
  2. O'Cearbhaill
    O'Cearbhaill
  3. Halton
    Halton
  4. Giralt
    Giralt
  5. Riviere
    Riviere
  6. Lesokhin
    Lesokhin
  7. Diamonte
    Diamonte
  8. Park
    Park
  9. Smith
    Smith
  10. Adusumilli
    Adusumilli

Groups

  1. Center for Hematologic Malignancies (26)
  2. Department of Medicine (26)
  3. GDMT, Medicine (26)
  4. Gynecologic Medicine Service (26)
  5. Gynecology Disease Management Team (26)
  6. Hematologic Malignancies Research (26)
  7. Hematologic Malignancies, Division of (26)
  8. Solid Tumor Oncology Division (26)
  9. GSK Faculty (19)
  10. Adult Leukemia (16)
  1. "Hematologic Malignancies Research"
  2. "Hematologic Malignancies, Division of"
  3. "Center for Hematologic Malignancies"
  4. "Gynecologic Medicine Service"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (12)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (26)
  2. Department of Medicine (26)
  3. GDMT, Medicine (26)
  4. Gynecologic Medicine Service (26)
  5. Gynecology Disease Management Team (26)
  6. Hematologic Malignancies Research (26)

More Groups

People
  1. Renier Brentjens (14)
  2. Roisin O'Cearbhaill (13)
  3. Elizabeth Halton (10)
  4. Isabelle Riviere (9)
  5. Sergio Giralt (9)
  6. Alexander Lesokhin (8)

More People

Years
  1. 2023 (1)
  2. 2021 (5)
  3. 2020 (1)
  4. 2019 (5)
  5. 2018 (5)
  6. 2016 (1)

More Years

Publications
  1. Blood (4)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Molecular Therapy - Methods & Clinical Development (2)
  4. Annals of Oncology (1)
  5. Bone Marrow Transplantation (1)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. Nature Publishing Group (5)
  3. American Society of Hematology (4)
  4. American Association for Cancer Research (3)
  5. American Society of Clinical Oncology (2)
  6. Biomed Central Ltd (2)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: A prospective observational cohort study
    Journal Article

    Korde, N.; Tavitian, E.; Mastey, D.; Lengfellner, J.; Hevroni, G.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Smith, E. L.; more...
    eClinicalMedicine (2023)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
    Journal Article

    Dao, T.; Klatt, M. G.; Korontsvit, T.; Mun, S. S.; Guzman, S.; Mattar, M.; Zivanovic, O.; Kyi, C. K.; Socci, N. D.; O’Cearbhaill, R. E.; more...
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save
  • OncoTree: A cancer classification system for precision oncology
    Journal Article

    Kundra, R.; Zhang, H.; Sheridan, R.; Sirintrapun, S. J.; Wang, A.; Ochoa, A.; Wilson, M.; Gross, B.; Sun, Y.; Madupuri, R.; more...
    JCO Clinical Cancer Informatics (2021)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save